Genetics impacts how quickly people metabolize the commonly prescribed anti-clotting drug clopidogrel (Plavix), but whether genetics affects cardiovascular outcomes of people taking the drug is a subject of debate.

The U.S. Food and Drug Administration (FDA) has updated the label information for the commonly used anti-clotting medication Plavix ® (clopidogrel) to stress to physicians that patients carrying certain genetic...

Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix ®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as...

A new report in the Journal of the American Medical Association adds to the mounting evidence that genetic variations impact the efficacy of clopidogrel (Plavix ®), a drug used to...

SNPwatch gives you the latest news about research linking various traits and conditions to individual genetic variations. These studies are exciting because they offer a glimpse into how genetics may...